Precigen, Inc. (PGEN) shareholders
Close on Nov 17, 2026Market cap $1.54BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Randal J. Kirk Joint filing with R.J. Kirk Declaration Of Trust (26.10%), Third Security, LLC (5.90%) | 133,956,416 | 35.90% | 13D (active) amendment | Mar 30, 2026 |
| Patient Capital Management, LLC Joint filing with Patient Opportunity Trust, a Series of Advisor Managed Portfolios (7.80%) | 36,006,800 | 10.20% | 13G (passive) amendment | Dec 31, 2025 |
| William H. Miller III Living Trust dated April 17, 2017 | 34,051,925 | 9.20% | 13G (passive) | Jun 26, 2025 |
| Ares Trading SA Joint filing with Merck Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany (8.30%), Merck KGaA, Darmstadt, Germany (8.30%) and 1 more | 20,647,152 | 8.30% | 13G (passive) amendment | Feb 14, 2024 |
| Steven A. Cohen Joint filing with Point72 Asset Management, L.P. (5.20%), Point72 Capital Advisors, Inc. (5.20%) | 18,383,242 | 5.20% | 13G (passive) | Jan 22, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PGEN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Patient Capital Management, LLC | 19,036,976 | 5.32% | $108.51M | +1,219,589 | 3.56% |
| BlackRock, Inc. | 17,146,921 | 4.79% | $97.74M | +1,923,730 | 0.00% |
| State Street Corp | 12,002,465 | 3.35% | $68.41M | +1,112,341 | 0.00% |
| Diametric Capital, LP | 9,269,926 | 2.59% | $52.84M | +2,468,138 | 5.57% |
| Vanguard Capital Management LLC | 7,906,160 | 2.21% | $45.07M | +757,164 | 0.00% |
| Tang Capital Management LLC | 6,417,500 | 1.79% | $36.58M | – | 1.66% |
| Boxer Capital Management, LLC | 5,150,000 | 1.44% | $29.36M | +1,650,000 | 2.21% |
| Geode Capital Management, LLC | 5,019,028 | 1.40% | $28.61M | +405,599 | 0.00% |
| Iridian Asset Management LLC/Ct | 4,031,963 | 1.13% | $22.98M | +439,233 | 7.90% |
| Occam Crest Management LP | 3,605,941 | 1.01% | $19.65M | −663,110 | 10.20% |
| Morgan Stanley | 3,469,628 | 0.97% | $19.78M | +1,055,306 | 0.00% |
| Goldman Sachs Group Inc | 3,406,456 | 0.95% | $19.42M | +55,979 | 0.00% |
| FMR LLC | 2,570,183 | 0.72% | $14.65M | +571,587 | 0.00% |
| Vanguard Portfolio Management LLC | 2,211,172 | 0.62% | $12.60M | +95,161 | 0.00% |
| First Trust Advisors LP | 2,014,659 | 0.56% | $11.48M | New | 0.01% |
| Bank Of America Corp /De/ | 1,848,414 | 0.52% | $10.54M | +377,135 | 0.00% |
| Arrowstreet Capital, Limited Partnership | 1,788,235 | 0.50% | $10.19M | +1,392,540 | 0.00% |
| Northern Trust Corp | 1,779,380 | 0.50% | $10.14M | +167,590 | 0.00% |
| Charles Schwab Investment Management Inc | 1,515,853 | 0.42% | $8.64M | +55,233 | 0.00% |
| Woodline Partners LP | 1,401,945 | 0.39% | $7.99M | +533 | 0.02% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 211 | 140M | 39.2% | 37 / 86 | 46 / 28 | 24M | 17M |
| Q1 2026 | 206 | 134M | 37.3% | 48 / 67 | 47 / 17 | 30M | 22M |
| Q4 2025 | 179 | 136M | 38.1% | 36 / 78 | 32 / 19 | 47M | 22M |
| Q3 2025 | 167 | 112M | 31.3% | 39 / 50 | 43 / 18 | 46M | 16M |
| Q2 2025 | 147 | 82M | 23.0% | 23 / 45 | 33 / 13 | 8M | 6M |
| Q1 2025 | 138 | 80M | 22.4% | 23 / 34 | 42 / 17 | 9M | 4M |
| Q4 2024 | 133 | 76M | 21.2% | 26 / 42 | 28 / 19 | 5M | 5M |
| Q3 2024 | 127 | 76M | 21.3% | 16 / 37 | 32 / 17 | 28M | 3M |
| Q2 2024 | 130 | 62M | 17.3% | 16 / 42 | 38 / 13 | 3M | 6M |
| Q1 2024 | 129 | 65M | 18.2% | 9 / 35 | 45 / 15 | 5M | 5M |
| Q4 2023 | 137 | 65M | 18.2% | 18 / 35 | 44 / 19 | 10M | 5M |
| Q3 2023 | 138 | 61M | 16.9% | 13 / 41 | 38 / 12 | 8M | 5M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
149 funds held PGEN in Q2 2026, 57% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of PGEN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Patient Opportunity Trust | 12,900,000 | 3.60% | $73.53M | 3.66% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 7,085,516 | 1.98% | $40.39M | 0.38% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 5,690,796 | 1.59% | $32.44M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 4,955,744 | 1.38% | $28.25M | 0.03% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 2,109,412 | 0.59% | $13.23M | 0.04% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 2,020,238 | 0.56% | $11.52M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 1,782,218 | 0.50% | $10.16M | 0.07% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund | 1,678,323 | 0.47% | $10.52M | 0.12% | Jul 31, 2026 |
| First Trust Small Cap Growth AlphaDEX Fund | 1,539,558 | 0.43% | $9.65M | 0.74% | Jul 31, 2026 |
| iShares Biotechnology ETF | 1,116,872 | 0.31% | $6.37M | 0.07% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 926,370 | 0.26% | $4.02M | 0.02% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 915,322 | 0.26% | $3.97M | 0.01% | May 31, 2026 |
| Fidelity Small Cap Growth K6 Fund | 870,590 | 0.24% | $5.46M | 0.12% | Jul 31, 2026 |
| Schwab U.S. Small-Cap ETF | 839,393 | 0.23% | $3.64M | 0.02% | May 31, 2026 |
| First Trust Small Cap Core AlphaDEX Fund | 765,206 | 0.21% | $4.80M | 0.35% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Harry Thomasian Jr. | Chief Financial Officer | 311,911 | 0.09% | Sep 24, 2026 |
| Donald P. Lehr | Chief Legal Officer | 758,181 | 0.21% | Aug 25, 2026 |
| Phil Tennant | Chief Commercial Officer | 221,158 | 0.06% | Aug 25, 2026 |
| Helen Sabzevari | President and CEO | 3,789,705 | 1.06% | Aug 25, 2026 |
| Rutul R. Shah | Chief Operating Officer | 468,865 | 0.13% | Aug 25, 2026 |
| Jeffrey B. Kindler | Director | 17,100 | 0.00% | Aug 28, 2026 |
| Nancy H. Agee | Director | 309,187 | 0.09% | Aug 25, 2026 |
| Randal J. Kirk | Director, 10% owner | 116,301,090 | 32.48% | Mar 31, 2026 |
| Vinita D. Gupta | Director | 669,027 | 0.19% | Mar 16, 2026 |
| Fred Hassan | Director | 1,243,239 | 0.35% | Mar 16, 2026 |
| Cesar L. Alvarez | Director | 782,909 | 0.22% | Mar 16, 2026 |
| Steven Frank | Director | 1,226,391 | 0.34% | Mar 16, 2026 |
| James S. Turley | Director | 685,417 | 0.19% | Mar 16, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Harry Thomasian Jr. Chief Financial Officer | Sep 23, 2026 | Option exercise | +42,918 | $2.33 | $100.00K | 311,911 |
| Harry Thomasian Jr. Chief Financial Officer | Sep 23, 2026 | Option exercise | +2 | $0.96 | $2 | 311,913 |
| Harry Thomasian Jr. Chief Financial Officer | Sep 23, 2026 | Option exercise | +1 | $1.21 | $1 | 311,914 |
| Harry Thomasian Jr. Chief Financial Officer | Sep 23, 2026 | Option exercise | +10,744 | $4.72 | $50.71K | 268,993 |
| Jeffrey B. Kindler Director | Aug 26, 2026 | Sale | −185,000 | $7.44 | $1.38M | 17,100 |
| Phil Tennant Chief Commercial Officer | Aug 25, 2026 | Option exercise | +79,166 | $1.61 | $127.46K | 221,158 |
| Phil Tennant Chief Commercial Officer | Aug 25, 2026 | Sale(10b5-1 plan) | −79,166 | $7.50 | $593.75K | 141,992 |
| Rutul R. Shah Chief Operating Officer | Aug 25, 2026 | Sale(10b5-1 plan) | −15,342 | $7.50 | $115.07K | 468,865 |
| Rutul R. Shah Chief Operating Officer | Aug 25, 2026 | Option exercise | +15,342 | $2.33 | $35.75K | 484,207 |
| Phil Tennant Chief Commercial Officer | Aug 23, 2026 | Option exercise | +5,208 | – | – | 144,577 |
| Phil Tennant Chief Commercial Officer | Aug 23, 2026 | Tax withholding | −2,585 | $7.20 | $18.61K | 141,992 |
| Rutul R. Shah Chief Operating Officer | Aug 23, 2026 | Tax withholding | −3,647 | $7.20 | $26.26K | 468,865 |
| Rutul R. Shah Chief Operating Officer | Aug 23, 2026 | Option exercise | +7,500 | – | – | 472,512 |
| Helen Sabzevari President and CEO | Aug 23, 2026 | Option exercise | +20,833 | – | – | 3,789,705 |
| Helen Sabzevari President and CEO | Aug 23, 2026 | Tax withholding | −10,184 | $7.20 | $73.32K | 3,779,521 |
| Harry Thomasian Jr. Chief Financial Officer | Aug 23, 2026 | Tax withholding | −3,577 | $7.20 | $25.75K | 258,249 |
| Harry Thomasian Jr. Chief Financial Officer | Aug 23, 2026 | Option exercise | +7,291 | – | – | 261,826 |
| Donald P. Lehr Chief Legal Officer | Aug 23, 2026 | Tax withholding | −2,488 | $7.20 | $17.91K | 758,181 |
| Donald P. Lehr Chief Legal Officer | Aug 23, 2026 | Option exercise | +5,208 | – | – | 760,669 |
| Rutul R. Shah Chief Operating Officer | Aug 21, 2026 | Sale(10b5-1 plan) | −34,658 | $7.50 | $259.94K | 465,012 |
| Rutul R. Shah Chief Operating Officer | Aug 21, 2026 | Option exercise | +34,658 | $2.33 | $80.75K | 499,670 |
| Nancy H. Agee Director | Aug 21, 2026 | Buy | +3,411 | $7.23 | $24.66K | 309,187 |
| Rutul R. Shah Chief Operating Officer | Aug 6, 2026 | Sale(10b5-1 plan) | −32,739 | $6.86 | $224.59K | 465,012 |
| Rutul R. Shah Chief Operating Officer | Aug 3, 2026 | Option exercise | +33,772 | $2.33 | $78.69K | 531,523 |
| Rutul R. Shah Chief Operating Officer | Aug 3, 2026 | Sale(10b5-1 plan) | −33,772 | $6.50 | $219.52K | 497,751 |
| Harry Thomasian Jr. Chief Financial Officer | Jul 31, 2026 | Sale(10b5-1 plan) | −100,000 | $6.06 | $606.00K | 254,535 |
| Harry Thomasian Jr. Chief Financial Officer | Jul 1, 2026 | Sale(10b5-1 plan) | −171,429 | $5.53 | $948.00K | 354,535 |
| Helen Sabzevari President and CEO | Jun 29, 2026 | Sale(10b5-1 plan) | −346,836 | $5.89 | $2.04M | 3,768,872 |
| Helen Sabzevari President and CEO | Jun 29, 2026 | Option exercise | +346,836 | $2.33 | $808.13K | 4,115,708 |
| Harry Thomasian Jr. Chief Financial Officer | Jun 29, 2026 | Sale(10b5-1 plan) | −28,571 | $5.78 | $165.14K | 525,964 |
| Rutul R. Shah Chief Operating Officer | Jun 29, 2026 | Sale(10b5-1 plan) | −42,924 | $5.85 | $251.11K | 497,751 |
| Rutul R. Shah Chief Operating Officer | Jun 29, 2026 | Option exercise | +42,924 | $2.33 | $100.01K | 540,675 |
| Phil Tennant Chief Commercial Officer | May 28, 2026 | Sale | −30,272 | $4.36 | $131.99K | 139,369 |
| Donald P. Lehr Chief Legal Officer | May 28, 2026 | Sale | −29,131 | $4.36 | $127.01K | 755,461 |
| Harry Thomasian Jr. Chief Financial Officer | May 28, 2026 | Sale | −41,884 | $4.36 | $182.61K | 554,535 |
| Rutul R. Shah Chief Operating Officer | May 28, 2026 | Sale | −42,703 | $4.36 | $186.19K | 497,751 |
| Helen Sabzevari President and CEO | May 28, 2026 | Sale | −119,250 | $4.36 | $519.93K | 3,768,872 |
| Helen Sabzevari President and CEO | May 23, 2026 | Option exercise | +250,000 | – | – | 3,888,122 |
| Phil Tennant Chief Commercial Officer | May 23, 2026 | Option exercise | +62,500 | – | – | 169,641 |
| Harry Thomasian Jr. Chief Financial Officer | May 23, 2026 | Option exercise | +87,500 | – | – | 596,419 |
| Donald P. Lehr Chief Legal Officer | May 23, 2026 | Option exercise | +62,500 | – | – | 784,592 |
| Rutul R. Shah Chief Operating Officer | May 23, 2026 | Option exercise | +90,000 | – | – | 540,454 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −1,108,998 | $3.30 | $3.66M | 80,672,818 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −38,976 | $3.30 | $128.62K | 302,213 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −2,334,420 | $3.30 | $7.70M | 12,262,741 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −23,789 | $3.30 | $78.50K | 423,984 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −50,797 | $3.30 | $167.63K | 426,695 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −370,847 | $3.30 | $1.22M | 3,238,210 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −152,063 | $3.30 | $501.81K | 1,463,571 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −50,797 | $3.30 | $167.63K | 425,732 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −426,199 | $3.30 | $1.41M | 3,358,917 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −168,794 | $3.30 | $557.02K | 1,425,544 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −47,101 | $3.30 | $155.43K | 519,061 |
| Helen Sabzevari President and CEO, Director | Mar 18, 2026 | Option exercise | +321,100 | – | – | 3,638,122 |
| Phil Tennant Chief Commercial Officer | Mar 18, 2026 | Option exercise | +42,110 | – | – | 107,141 |
| Donald P. Lehr Chief Legal Officer | Mar 18, 2026 | Option exercise | +40,443 | – | – | 722,092 |
| Rutul R. Shah Chief Operating Officer | Mar 18, 2026 | Option exercise | +44,495 | – | – | 450,454 |
| Harry Thomasian Jr. Chief Financial Officer | Mar 18, 2026 | Option exercise | +40,293 | – | – | 508,919 |
| Randal J. Kirk Director, 10% owner | Mar 13, 2026 | Option exercise | +143,678 | – | – | 81,781,816 |
| James S. Turley Director | Mar 13, 2026 | Option exercise | +71,839 | – | – | 685,417 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Precigen's stock actually held short. Settlement fails (shares not delivered on time) peaked at 113,406 shares on Aug 28, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Jeffrey B. Kindler Director | Aug 26, 2026 | 185,000 | $1.37M | Aug 26, 2026 | Acquired as compensation -- Restricted Stock Units |
| Phil Tennant Officer | Aug 25, 2026 | 79,166 | $593.75K | Aug 25, 2026 | Stock Option Exercise |
| Rutul R. Shah Officer | Aug 25, 2026 | 15,342 | $115.07K | Aug 25, 2026 | Stock Option Exercise |
| Rutul R. Shah Officer | Aug 21, 2026 | 34,658 | $259.94K | Aug 21, 2026 | Stock Option Exercise |
| Rutul R. Shah Officer | Aug 6, 2026 | 32,739 | $224.59K | Aug 6, 2026 | Restricted Stock Vesting |
| Rutul R. Shah Officer | Aug 3, 2026 | 33,772 | $219.52K | Aug 3, 2026 | Stock Option Exercise |
| Harry Thomasian Jr. Officer | Jul 31, 2026 | 100,000 | $605.61K | Jul 31, 2026 | Restricted Stock Vesting |
| Harry Thomasian Jr. Officer | Jul 1, 2026 | 171,429 | $948.54K | Jul 1, 2026 | Restricted Stock Vesting |
| Harry Thomasian Jr. Officer | Jun 29, 2026 | 28,571 | $165.20K | Jun 29, 2026 | Open Market Purchase |
| Rutul R. Shah Officer | Jun 29, 2026 | 42,924 | $251.11K | Jun 29, 2026 | Stock Option Exercise |
| Helen Sabzevari Officer, Director | Jun 29, 2026 | 346,836 | $2.04M | Jun 29, 2026 | Stock Option Exercise |
| Randal J. Kirk Director, 10% Shareholder | Mar 30, 2026 | 4,772,781 | $17.52M | Mar 30, 2026 | Private Placement |
| Randal J. Kirk Director, 10% Shareholder | Dec 22, 2025 | 1,900,036 | $8.21M | Dec 22, 2025 | Secondary Public Offering |
| Jeffrey B. Kindler Director | Dec 12, 2025 | 235,467 | $868.87K | Dec 12, 2025 | Acquired as compensation -- Restricted Stock Units |
| Randal J. Kirk Director, 10% Stockholder | Nov 20, 2025 | 942,832 | $3.84M | Nov 20, 2025 | Public offering of shares by Company |
Congress trades
4 trades in Precigen reported by 2 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Thomas Suozzi NY03 | Sold | Dec 14, 2018 | $1K–15K | Sep 23, 2021 1014 days late |
| Thomas Suozzi NY03 | Bought | Dec 6, 2017 | $1K–15K | Sep 23, 2021 1387 days late |
| William L. Owens NY21 | Sold | Sep 8, 2014 | $1K–15K | Sep 10, 2014 |
| William L. Owens NY21 | Sold | May 12, 2014 | $1K–15K | May 20, 2014 |
See a number that looks wrong?